Income Statement

v3.7.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
3 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Operating expenses:    
Research and development $ 1,096,200 $ 825,700
General and administrative 1,164,300 1,137,600
Total operating expenses 2,260,500 1,963,300
Loss from operations (2,260,500) (1,963,300)
Other expenses, net:    
Interest expense, net (2,400) (1,400)
Loss before income taxes (2,262,900) (1,964,700)
Income taxes (2,400) (2,400)
Net loss (2,265,300) (1,967,100)
Accrued dividends on Series B Preferred stock (247,300) (539,800)
Deemed dividend on Series B Preferred Units 0 (111,100)
Net loss attributable to common stockholders $ (2,512,600) $ (2,618,000)
Basic and diluted net loss attributable to common stockholders per common share $ (0.28) $ (0.51)
Weighted average shares used in computing basic and diluted net loss attributable to common stockholders per common share 9,034,213 5,097,832

Source